Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07175129 · ClinicalTrials.gov registry record · NA
Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)
A NA study of Chronic Limb-Threatening Ischemia, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07175129: Recruiting NA study of Chronic Limb-Threatening Ischemia, sponsored by University Hospitals Cleveland Medical Center.
NCT07175129 is a NA study of Chronic Limb-Threatening Ischemia that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 10 participants, below the 184-participant average among 9 other Chronic Limb-Threatening Ischemia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07175129, a NA study of Chronic Limb-Threatening Ischemia, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic limb-threatening ischemia (CLTI) is a serious condition that happens when blood flow to the legs or feet is severely reduced. This can lead to constant pain, wounds that don't heal, infections, and in some cases, the need for amputation. Some people with CLTI have such severe artery disease that doctors are unable to restore blood flow using standard treatments like surgery or stents. For these patients, major amputation may be the only remaining option. This study aims to test a new surgical technique called transverse tibial bone transport, which has been shown in some previous small studies to help improve blood flow and promote healing of wounds in the legs and feet. These early studies suggest that the procedure may help wounds heal better and reduce the need for amputation in people with severe circulation problems. This research will help us learn more about how safe and effective this technique is for patients who have no other treatment options other than amputation.
Conditions Studied
Interventions
- PROCEDURE Transverse Tibial Bone Transport
- DEVICE TrueLok Elevate
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07175129 shows while recruiting
NCT07175129 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 184-participant average among 9 other Chronic Limb-Threatening Ischemia trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Chronic Limb-Threatening Ischemia appearing as the primary indexed condition, and to 2 interventions - of which Transverse Tibial Bone Transport is the first listed.
NCT07175129 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07175129 about?
NCT07175129 is a clinical study titled "Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)". Chronic limb-threatening ischemia (CLTI) is a serious condition that happens when blood flow to the legs or feet is severely reduced. This can lead to constant pain, wounds that don't heal, infections, and in some cases, the need for amputation. Some people with CLTI have such severe artery disease...
What is the current status of trial NCT07175129?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-01-05. Estimated completion is 2027-06.
What conditions does trial NCT07175129 study?
This clinical trial studies the following conditions: Chronic Limb-Threatening Ischemia.
What interventions are being tested in trial NCT07175129?
The interventions under investigation include: Transverse Tibial Bone Transport (PROCEDURE), TrueLok Elevate (DEVICE).
Who is sponsoring clinical trial NCT07175129?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07175129 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Limb-Threatening Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07175129's enrollment target sits among peer trials
10 10th of 9 the lowest of 9 other Chronic Limb-Threatening Ischemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Limb-Threatening Ischemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
RECRUITING · NA
-
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
RECRUITING · NA
-
AcoArt Litos PCB Below-the-knee Global Trial
RECRUITING · NA
-
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
RECRUITING · NA
-
Esprit BTK Post-Approval Study
RECRUITING · NA
-
The ROAMM-EHR Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI